Phathom Pharmaceuticals, Inc. (PHAT)

Phathom Pharmaceuticals Revenue

In the year 2025, Phathom Pharmaceuticals had annual revenue of $175.11M with 216.93% growth. Phathom Pharmaceuticals had revenue of $57.58M in the quarter ending December 31, 2025, with 94.12% growth.

• Revenue (ttm): $175.11M
• Revenue Growth: +216.93%
• P/S Ratio: 5.73
• Revenue / Employee: $471,995
• Employees: 371
• Market Cap: 1.00B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	175.11M	119.86M	216.93%
Dec 31, 2024	55.25M	54.57M	8,001.47%
Dec 31, 2023	682.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-